Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
Letter

Utility and Significance of Gadolinium-Based Contrast Enhancement in Posterior Reversible Encephalopathy Syndrome

V. Bhatia, V. Gupta and N. Khandelwal
American Journal of Neuroradiology September 2016, 37 (9) E58; DOI: https://doi.org/10.3174/ajnr.A4847
V. Bhatia
aDepartment of Radio-Diagnosis Postgraduate Institute of Medical Education and Research Chandigarh, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for V. Bhatia
V. Gupta
aDepartment of Radio-Diagnosis Postgraduate Institute of Medical Education and Research Chandigarh, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for V. Gupta
N. Khandelwal
aDepartment of Radio-Diagnosis Postgraduate Institute of Medical Education and Research Chandigarh, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for N. Khandelwal
  • Article
  • Info & Metrics
  • References
  • PDF
Loading

We read with considerable interest the article concerning the significance of gadolinium-based contrast enhancement in patients with posterior reversible encephalopathy syndrome (PRES).1 The authors have performed a retrospective study on a large patient population and have demonstrated that gadolinium administration is not warranted in these patients because PRES is a clinical-radiologic diagnosis made in appropriate settings and the presence or lack of contrast enhancement does not add to the existing diagnosis algorithm or help in the prognosis of the patients.

A few points merit consideration after reading this article. First, they included 135 patients with a mean age of 40 ± 20 years with range from 7 to 82 years. However, they have not separately mentioned the pediatric patients, who have been shown to follow a different clinical-radiologic spectrum.1 In our review of pediatric patients with PRES, we have found that contrast enhancement is variably seen in pediatric populations, ranging from 2% to 53%. This variability is likely due to the multiple etiologies leading to PRES, with imaging in patients having hemato-oncologic malignancies and undergoing chemotherapy predominantly showing enhancement. In our own pediatric PRES cohort, renal disease was seen in 62.5% of patients and contrast could not be given. Only 2 patients undergoing chemotherapy showed leptomeningeal enhancement. In addition, pediatric patients commonly show atypical MR imaging findings.2 These findings indicate that endothelial dysfunction may be the primary mechanism in addition to loss of autoregulation.

We also did not find any correlation among contrast enhancement, MR imaging severity of disease, and patient outcome in our pediatric PRES cohort. A description from the authors of their pediatric cohort, with underlying diseases and pattern of enhancement, may further add to our existing knowledge.

Second, they compared the clinical outcome with the MR imaging severity index as described previously. However, as per our review, the pediatric population frequently shows atypical findings such as frontal lobe, basal ganglia, and brain stem involvement2; thus, the conventional MR imaging severity index, based on location, may not be applicable when assessing the prognostic significance in children.

We find the published article useful because it reinforces our own experience of not using contrast unless some alternative pathology is being considered. A pediatric population in which the predominant etiologic cohort is underlying renal disease may not be given contrast, and other patients with PRES may not benefit much from contrast administration as far as diagnosis and clinical outcome are concerned.

References

  1. 1.↵
    1. Karia SJ,
    2. Rykken JB,
    3. McKinney JK, et al
    . Utility and significance of gadolinium-based contrast enhancement in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2016;37:415–22 doi:10.3174/ajnr.A4563 pmid:26564441
    Abstract/FREE Full Text
  2. 2.↵
    1. Gupta V,
    2. Bhatia V,
    3. Khandelwal N, et al
    . Imaging findings in pediatric posterior reversible encephalopathy syndrome (PRES): 5 years of experience from a tertiary care center in India. J Child Neurol 2016 Apr 12. [Epub ahead of print] doi:10.1177/0883073816643409 pmid:27071468
    Abstract/FREE Full Text
  • © 2016 by American Journal of Neuroradiology
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 37 (9)
American Journal of Neuroradiology
Vol. 37, Issue 9
1 Sep 2016
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Utility and Significance of Gadolinium-Based Contrast Enhancement in Posterior Reversible Encephalopathy Syndrome
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Utility and Significance of Gadolinium-Based Contrast Enhancement in Posterior Reversible Encephalopathy Syndrome
V. Bhatia, V. Gupta, N. Khandelwal
American Journal of Neuroradiology Sep 2016, 37 (9) E58; DOI: 10.3174/ajnr.A4847

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Utility and Significance of Gadolinium-Based Contrast Enhancement in Posterior Reversible Encephalopathy Syndrome
V. Bhatia, V. Gupta, N. Khandelwal
American Journal of Neuroradiology Sep 2016, 37 (9) E58; DOI: 10.3174/ajnr.A4847
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • References
  • Info & Metrics
  • References
  • PDF

Related Articles

  • Reply:
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2020 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2021 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire